High-Alert Medication Safety for Nurses

High-alert medications are drugs that carry a significantly elevated risk of causing serious patient harm or death when used in error. The Institute for Safe Medication Practices (ISMP) identifies these based on reported patient injury data, not on how frequently errors occur.

A medication can be high-alert because a small dosing error causes catastrophic harm (e.g., concentrated potassium chloride), because the therapeutic window is narrow (e.g., anticoagulants), or because the medication class has multiple look-alike or sound-alike members with vastly different effects (e.g., insulin types).

Key Safety Rules

• Never abbreviate “units” — writing “U” or “IU” can be misread as a zero, causing 10× overdose
• Verify type before administration — clear vs. cloudy insulins are not interchangeable (clear = rapid/long-acting; cloudy = NPH)
• Use insulin-specific syringes — never use a tuberculin syringe for insulin; unit markings differ
• Independent double-check — required by most facilities for IV insulin infusions and high-dose calculations
• Always check blood glucose before administering and monitor post-administration per protocol
• Hypoglycemia reversal ready — dextrose 50%, glucagon, and oral glucose should be immediately accessible

• Verify the correct anticoagulant — heparin and enoxaparin (LMWH) are not interchangeable; never substitute one for the other
• Heparin infusions require aPTT monitoring per protocol; warfarin requires INR monitoring
• Know the reversal agent: protamine sulfate reverses heparin; vitamin K and FFP reverse warfarin; specific reversal agents exist for DOACs (andexanet alfa, idarucizumab)
• Assess for bleeding at every assessment: gums, urine color, hematoma, blood pressure trends
• Hold anticoagulants before invasive procedures and verify resume timing with provider
• Educate patients on fall prevention, avoiding NSAIDs, and signs of bleeding

• Assess respiratory rate and sedation level before every opioid dose — hold if RR <12 or excessive sedation
• Never equate morphine with hydromorphone — hydromorphone is approximately 5–7× more potent; dose confusion causes fatal overdoses
• Keep naloxone (Narcan) accessible; know facility reversal protocol
• PCA (patient-controlled analgesia) pumps: only the patient presses the button — no proxy dosing by nurses or family
• Monitor for opioid-induced constipation — bowel regimen is standard with scheduled opioid use

• Concentrated KCl (potassium chloride) must never be available as a floor stock med. IV KCl must be administered via IV pump; maximum rate is 10 mEq/hr via peripheral IV (up to 20 mEq/hr only with continuous cardiac monitoring, typically via central access)
• Hypertonic saline (3%) requires dedicated central access; rapid correction of hyponatremia causes osmotic demyelination syndrome
• Magnesium sulfate infusions require calcium gluconate at bedside as antidote; monitor for loss of deep tendon reflexes (early toxicity)
• All concentrated electrolyte infusions require continuous cardiac monitoring

An independent double-check (IDC)requires a second nurse to verify high-alert medication preparation and administration without seeing the first nurse's calculations. It is not a casual second look — both nurses must independently calculate before comparing answers.

IDC is typically required for:

• IV insulin infusions
• IV heparin infusions
• IV chemotherapy
• Concentrated electrolyte infusions
• PCA pump programming changes
• High-dose opioid infusions

IDC process: Nurse A draws up or programs. Nurse B independently calculates and verifies dose, rate, route, patient ID, and pump settings. Both document the double-check in the MAR.